| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |